莫努匹韦的用量是多少？使用莫努匹韦治疗有哪些副作用

Molnupiravir is a prodrug that is metabolized to the ribonucleoside analog N-hydroxycytidine (NHC), which is distributed in cells and is phosphorylated in cells to form pharmacologically active ribonucleoside triphosphate (NHC-TP). Molnupiravir is the world's first oral antiviral drug approved for the treatment of mild to moderate COVID-19 infection in adults. What is the dosage of that? What are the side effects of treatment with monupivir?

Monupivir dosage

The recommended dose of Molnupiravir is: 800 mg (four 200 mg capsules) taken orally every 12 hours for 5 days. The safety and effectiveness of Molnupiravir when administered for more than 5 days has not been established. Molnupiravir should be taken as soon as possible after COVID-19 is diagnosed or within 5 days of the onset of symptoms. Due to the different disease progression, personal constitution and drug tolerance of each patient, the dosage and treatment time of Molnupiravir treatment will also be different. Patients should strictly follow the doctor's instructions to take medication, so as to obtain better therapeutic effects.

Monupivir side effects

Side effects of Monupivir include: diarrhea, nausea, dizziness, headache, vomiting, rash, urticaria, etc. Because each patient's disease progresses differently, patients may experience different side effects after treatment with Molnupiravir, as well as the severity and timing of side effects. If patients experience serious side effects while receiving Molnupiravir, they should go to the hospital immediately and receive regular treatment from a professional doctor. After adverse reactions occur, patients should not blindly use other drug treatments to avoid causing more adverse reactions and affecting their condition.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended hot articles